The health-care world watched and waited for a final decision since the Supreme Court held three-days of hearings in March on the constitutionality of President Obama’s Affordable Care Act. Since the Obama administration passed the law in March 2010, the Bloomberg Government health-care analyst team has been studying and analyzing the possible impacts of this historical decision on the health-care industry, companies and individuals.
The study below helps to explain the impacts of the court limiting Medicaid expansion:
Supreme Court Ruling May Undermine Increase In Medicaid Spending
Published March 9, 2012
This Bloomberg Government Study examines the size and scoop of the projected revenue that the Medicaid program will direct to companies doing business in the 27 states that have filed suit over the constitutionality of the overhaul law. It looks at the impact a ruling against the law would have on managed care plans, nursing homes and inpatient hospitals, the top recipients of Medicaid spending, projected over a five-year period from 2014 to 2018. It also looks at the potential impact on health-care providers in Florida and Virginia, the two lead litigant states.
AN ANALYSIS OF THE SUPREME COURT’S HEALTH-CARE DECISION
Bloomberg Government invites you to join a panel of health-care experts for a free live webinar to hear their perspectives on the Supreme Court decision and answer your questions.
Friday, June 29, 2012
10:00 am – 11:00 am EST
Register here.
More about the Bloomberg Government Health-Care Analyst Team:
Matt Barry is the health analyst team leader for Bloomberg Government. His primary beats include the Affordable Care Act, Medicare, Medicaid, public health and prevention. Matt has nearly than 25 years of health-policy experience, having worked in both the executive and legislative branches of the federal government, nonprofits and private consulting and public affairs firms. He has worked on a range of issues covering payment and access issues under the Affordable Care Act, Medicare and Medicaid, tobacco control policy, rural health care, and childhood immunization policy.
Christopher Flavelle is a health-care policy analyst for Bloomberg Government. He holds a master’s degree from Columbia University’s School of International and Public Affairs and a bachelor’s degree from McGill University. Before Bloomberg, he examined the 2009 U.S. stimulus package for ProPublica, the investigative news group in New York.
Peter Gosselin is a senior health policy analyst with Bloomberg Government. He had been a special economic adviser for health reform at the Department of Health and Human Services and chief speechwriter to Treasury Secretary Timothy F. Geithner. Prior to his stint in government, Gosselin spent 35 years in newspapers, most recently as chief economics correspondent for the Los Angeles Times. He has a bachelor’s degree from Brown University and an MBA in economics from Columbia Business School.
Brian Rye is a health-care financial analyst with Bloomberg Government. Before joining
Bloomberg, he spent 12 years as an equity research analyst at SunTrust, Raymond James and Janney Montgomery Scott. In those capacities, he followed biotech, pharmaceutical and other health-care companies. Rye also served as a senior business management analyst for Booz Allen Hamilton’s civil health group. He received a bachelor’s degree in economics from Vanderbilt University and holds the Chartered Financial Analyst designation.
Please visit the live blog on Bloomberg.com for updates throughout the day.